Correction

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)

John C. Byrd, Stephen Smith, Nina Wagner-Johnston, Jeff Sharman, Andy Chen, Ranjana Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame Okrah, Lichuan Liu, Elaine Murray, Elicia Penuel, Ashley F. Ward, Ian W. Flinn

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: Due to errors in figure preparation, the data for Table 3 was listed incorrectly. It has now been updated with corrected numbers (see text in Table 3) and the resulting graphs (Figure 2A and 2B) have been updated as well. In addition, the reference list for this paper was accidentally alphabetized during the production process, while citation numbers within the article remained according to first-mention. In this correction, the entire references list has been corrected. We include the reference list in their order of mention so that the citation number in the article corresponds to the reference number in the list.(Table Persented).

Original languageEnglish (US)
Pages (from-to)3827-3830
Number of pages4
JournalOncotarget
Volume10
Issue number38
DOIs
StatePublished - Jan 1 2019

Fingerprint

B-Lymphocytes

ASJC Scopus subject areas

  • Oncology

Cite this

Correction : First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310). / Byrd, John C.; Smith, Stephen; Wagner-Johnston, Nina; Sharman, Jeff; Chen, Andy; Advani, Ranjana; Augustson, Bradley; Marlton, Paula; Renee Commerford, S.; Okrah, Kwame; Liu, Lichuan; Murray, Elaine; Penuel, Elicia; Ward, Ashley F.; Flinn, Ian W.

In: Oncotarget, Vol. 10, No. 38, 01.01.2019, p. 3827-3830.

Research output: Contribution to journalComment/debate

Byrd, JC, Smith, S, Wagner-Johnston, N, Sharman, J, Chen, A, Advani, R, Augustson, B, Marlton, P, Renee Commerford, S, Okrah, K, Liu, L, Murray, E, Penuel, E, Ward, AF & Flinn, IW 2019, 'Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)', Oncotarget, vol. 10, no. 38, pp. 3827-3830. https://doi.org/10.18632/oncotarget.27011
Byrd, John C. ; Smith, Stephen ; Wagner-Johnston, Nina ; Sharman, Jeff ; Chen, Andy ; Advani, Ranjana ; Augustson, Bradley ; Marlton, Paula ; Renee Commerford, S. ; Okrah, Kwame ; Liu, Lichuan ; Murray, Elaine ; Penuel, Elicia ; Ward, Ashley F. ; Flinn, Ian W. / Correction : First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310). In: Oncotarget. 2019 ; Vol. 10, No. 38. pp. 3827-3830.
@article{849b4554afc84224a7cd178c8a0073cf,
title = "Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)",
abstract = "This article has been corrected: Due to errors in figure preparation, the data for Table 3 was listed incorrectly. It has now been updated with corrected numbers (see text in Table 3) and the resulting graphs (Figure 2A and 2B) have been updated as well. In addition, the reference list for this paper was accidentally alphabetized during the production process, while citation numbers within the article remained according to first-mention. In this correction, the entire references list has been corrected. We include the reference list in their order of mention so that the citation number in the article corresponds to the reference number in the list.(Table Persented).",
author = "Byrd, {John C.} and Stephen Smith and Nina Wagner-Johnston and Jeff Sharman and Andy Chen and Ranjana Advani and Bradley Augustson and Paula Marlton and {Renee Commerford}, S. and Kwame Okrah and Lichuan Liu and Elaine Murray and Elicia Penuel and Ward, {Ashley F.} and Flinn, {Ian W.}",
year = "2019",
month = "1",
day = "1",
doi = "10.18632/oncotarget.27011",
language = "English (US)",
volume = "10",
pages = "3827--3830",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "38",

}

TY - JOUR

T1 - Correction

T2 - First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)

AU - Byrd, John C.

AU - Smith, Stephen

AU - Wagner-Johnston, Nina

AU - Sharman, Jeff

AU - Chen, Andy

AU - Advani, Ranjana

AU - Augustson, Bradley

AU - Marlton, Paula

AU - Renee Commerford, S.

AU - Okrah, Kwame

AU - Liu, Lichuan

AU - Murray, Elaine

AU - Penuel, Elicia

AU - Ward, Ashley F.

AU - Flinn, Ian W.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This article has been corrected: Due to errors in figure preparation, the data for Table 3 was listed incorrectly. It has now been updated with corrected numbers (see text in Table 3) and the resulting graphs (Figure 2A and 2B) have been updated as well. In addition, the reference list for this paper was accidentally alphabetized during the production process, while citation numbers within the article remained according to first-mention. In this correction, the entire references list has been corrected. We include the reference list in their order of mention so that the citation number in the article corresponds to the reference number in the list.(Table Persented).

AB - This article has been corrected: Due to errors in figure preparation, the data for Table 3 was listed incorrectly. It has now been updated with corrected numbers (see text in Table 3) and the resulting graphs (Figure 2A and 2B) have been updated as well. In addition, the reference list for this paper was accidentally alphabetized during the production process, while citation numbers within the article remained according to first-mention. In this correction, the entire references list has been corrected. We include the reference list in their order of mention so that the citation number in the article corresponds to the reference number in the list.(Table Persented).

UR - http://www.scopus.com/inward/record.url?scp=85066929964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066929964&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.27011

DO - 10.18632/oncotarget.27011

M3 - Comment/debate

VL - 10

SP - 3827

EP - 3830

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 38

ER -